Related Experiment Video
Updated: Jan 13, 2026

11:30
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
25.1K
Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid
Suresh Ambati1, Yeqi Li2, Matthew K Whittaker3
1Davison Life Sciences Bld., Green Street, Department of Genetics, University of Georgia, Athens, GA 30602 USA.
Summary
Researchers developed Encapsulated Proteins in Lipid NanoParticles (EP-LNPs) for efficient intracellular protein delivery. This novel technology overcomes cell membrane barriers, enabling functional protein therapeutics for various applications.
Area of Science:
- Biotechnology
- Nanomedicine
- Cell Biology
Background:
- Protein therapeutics face limitations due to poor cell membrane permeability.
- Existing delivery methods are restricted to cell surface or serum targets.
- Lipid nanoparticles offer a potential solution for intracellular delivery of polar molecules.
Purpose of the Study:
- To develop a method for efficient encapsulation and intracellular delivery of functional proteins using lipid nanoparticles.
- To investigate the association of amphoteric proteins with anionic lipids for nanoparticle assembly.
- To demonstrate the efficacy of Encapsulated Proteins in Lipid NanoParticles (EP-LNPs) for cellular uptake and protein functionality.
Main Methods:
- Utilized anionic lipids to facilitate protein association and microfluidic chip assembly of EP-LNPs.
- Encapsulated proteins with diverse molecular weights and isoelectric points.
- Assessed encapsulation efficiency, stability, cellular uptake in mammalian and fungal cells, and intracellular protein functionality.
Main Results:
- Achieved high encapsulation efficiencies (70-90%) for proteins in EP-LNPs at a 1:20 protein:lipid ratio.
- Demonstrated long-term stability of encapsulated proteins (several months).
- Showcased efficient cellular entry of EP-LNPs into mammalian and fungal cells, with functional intracellular proteins.
Conclusions:
- EP-LNPs technology enables efficient and functional intracellular delivery of proteins.
- This platform overcomes cell membrane barriers, expanding the scope of protein therapeutics.
- Potential applications include delivery of antibodies, enzymes, and other protein-based drugs.

